Literature DB >> 23199007

Low- versus high-dose rituximab for antibody-mediated rejection after kidney transplantation.

Julie Bellière, Lionel Rostaing, Céline Guilbeau-Frugier, Nicolas Congy, Nassim Kamar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23199007     DOI： 10.1111/tri.12015

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  2 in total

1.  Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients.

Authors:  F Ahmadi; S Dashti-Khavidaki; M R Khatami; M Gatmiri; F Ahmadi; M Mahdavi-Mazdeh; M T Najafi; Z Foroozanfar; A Mahdizadeh; S Derafshi
Journal:  Int J Organ Transplant Med       Date:  2019

2.  Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.

Authors:  Opas Traitanon; James M Mathew; Giovanna La Monica; Luting Xu; Valeria Mas; Lorenzo Gallon
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.